Triple-negative breast cancer patients should undergo genetic screening

2 diciembre 2014

Most patients with triple-negative breast cancer should undergo genetic testing for mutations in known breast cancer predisposition genes, including BRCA1 and BRCA2, a study has found. The findings come from the largest analysis to date of genetic mutations in this aggressive form of breast cancer.